Cronos Group (CRON) Competitors $2.30 +0.03 (+1.32%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.28 -0.02 (-1.09%) As of 08/8/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRON vs. ACB, CGC, OGI, SNDL, TLRY, APLS, HCM, MOR, KYMR, and IMVTShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Apellis Pharmaceuticals (APLS), HUTCHMED (HCM), MorphoSys (MOR), Kymera Therapeutics (KYMR), and Immunovant (IMVT). These companies are all part of the "pharmaceutical products" industry. Cronos Group vs. Its Competitors Aurora Cannabis Canopy Growth Organigram Global SNDL Tilray Brands Apellis Pharmaceuticals HUTCHMED MorphoSys Kymera Therapeutics Immunovant Aurora Cannabis (NASDAQ:ACB) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations. Is ACB or CRON more profitable? Cronos Group has a net margin of 14.19% compared to Aurora Cannabis' net margin of -5.66%. Aurora Cannabis' return on equity of -1.49% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-5.66% -1.49% -1.06% Cronos Group 14.19%-3.78%-3.62% Which has preferable earnings & valuation, ACB or CRON? Cronos Group has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.03$1.63M-$0.19-23.58Cronos Group$117.61M7.51$41.08M$0.0546.00 Do insiders & institutionals have more ownership in ACB or CRON? 47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Comparatively, 6.9% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media favor ACB or CRON? In the previous week, Aurora Cannabis had 2 more articles in the media than Cronos Group. MarketBeat recorded 7 mentions for Aurora Cannabis and 5 mentions for Cronos Group. Cronos Group's average media sentiment score of -0.13 beat Aurora Cannabis' score of -0.44 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Cronos Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate ACB or CRON? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, ACB or CRON? Aurora Cannabis has a beta of 1.84, indicating that its stock price is 84% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. SummaryAurora Cannabis beats Cronos Group on 9 of the 16 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$882.76M$2.42B$5.50B$9.72BDividend YieldN/A1.78%4.59%4.12%P/E Ratio46.0020.3930.0224.70Price / Sales7.51699.22455.90100.54Price / CashN/A23.6624.8428.01Price / Book0.795.098.525.76Net Income$41.08M$31.61M$3.27B$267.05M7 Day Performance17.95%0.01%6.14%5.08%1 Month Performance9.52%-1.53%0.07%0.61%1 Year Performance4.55%5.85%36.43%22.83% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos Group0.9524 of 5 stars$2.30+1.3%N/A+4.5%$882.76M$117.61M46.00450News CoverageEarnings ReportAnalyst DowngradeAnalyst RevisionHigh Trading VolumeACBAurora Cannabis0.4862 of 5 stars$4.62+3.1%N/A-30.7%$259.86M$343.29M42.001,130News CoverageEarnings ReportAnalyst RevisionCGCCanopy Growth0.5466 of 5 stars$1.10+4.8%N/A-80.4%$225.66M$269.00M-0.273,150News CoverageEarnings ReportGap UpOGIOrganigram Global0.7262 of 5 stars$1.38+3.8%N/A-1.7%$184.96M$194.09M13.80860Upcoming EarningsSNDLSNDL2.7805 of 5 stars$1.64-0.6%$4.00+143.9%-18.4%$430.95M$944.25M-6.072,516TLRYTilray Brands3.0252 of 5 stars$0.61+6.9%$1.92+215.3%-63.8%$611.75M$210.48M-0.262,650Options VolumeAPLSApellis Pharmaceuticals4.7044 of 5 stars$24.26+5.7%$37.78+55.7%-34.2%$3.05B$754.65M-13.33770HCMHUTCHMED3.1076 of 5 stars$17.28+0.1%$28.00+62.0%-24.5%$3.01B$630.20M0.001,811News CoveragePositive NewsAnalyst DowngradeMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730KYMRKymera Therapeutics3.3176 of 5 stars$43.66+1.6%$59.11+35.4%-2.0%$2.84B$58.89M-14.08170Upcoming EarningsIMVTImmunovant1.5172 of 5 stars$16.09+2.4%$36.40+126.2%-47.1%$2.75BN/A-5.87120 Related Companies and Tools Related Companies ACB Alternatives CGC Alternatives OGI Alternatives SNDL Alternatives TLRY Alternatives APLS Alternatives HCM Alternatives MOR Alternatives KYMR Alternatives IMVT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRON) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
